Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.48 |
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL27719616 | 0.98 | TSHR (0.52) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| Ethylene Glycol SCHEMBL28157678 | 0.92 | TP53 (0.46) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL8322257 | 0.86 | TSHR (0.42) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL13898479 | 0.83 | TSHR (0.50) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL595998 | 0.82 | MAPT (0.46) | ALDH1A1SMN1; SMN2KMT2AHPGDMAPK1 | |
| SCHEMBL11612820 | 0.82 | HDAC8 (0.42) | ALDH1A1SMN1; SMN2KMT2ARXRARXRB | |
| SCHEMBL372015 | 0.81 | TSHR (0.60) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL31192242 | 0.81 | TSHR (0.60) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL3980828 | 0.81 | TSHR (0.60) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL4642822 | 0.81 | TSHR (0.60) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638706-A2 | NANOFIBROUS SCAFFOLD FOR CELL CULTURING | Cellevate AB (SE) | 2025-10-29 | — | — | EP | claimed |
| CN-119504600-A | Etomidate hapten as well as preparation method and application thereof | 深圳市绿诗源生物技术有限公司 | 2025-02-25 | — | — | CN | claimed |
| WO-2024133700-A2 | NANOFIBROUS SCAFFOLD FOR CELL CULTURING | CELLEVATE AB (SE) | 2024-06-27 | — | — | WO | claimed |
| CN-105348206-A | Paclobutrazol semiantigen, antigen, antibody and preparation method | WANG QIUYAN | 2016-02-24 | — | — | CN | claimed |
| EP-4638706-A2 | NANOFIBROUS SCAFFOLD FOR CELL CULTURING | Cellevate AB (SE) | 2025-10-29 | — | — | EP | disclosed |
| EP-4638707-A1 | NANOFIBROUS SCAFFOLD FOR INDUSTRIAL SCALE CELL CULTURING | Cellevate AB (SE) | 2025-10-29 | — | — | EP | disclosed |
| US-12297302-B2 | Amphiphilic compound, and medical resin composition and pharmaceutical additive using the same | NIPPON SHOKUBAI CO., LTD. (JP) | 2025-05-13 | — | — | US | disclosed |
| CN-119504600-A | Etomidate hapten as well as preparation method and application thereof | 深圳市绿诗源生物技术有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-20250041430-A1 | CONJUGATE COMPOUND AND METHOD FOR PRODUCING CONJUGATE COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2025-02-06 | — | — | US | disclosed |
| WO-2024133634-A1 | NANOFIBROUS SCAFFOLD FOR INDUSTRIAL SCALE CELL CULTURING | CELLEVATE AB (SE) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024133700-A2 | NANOFIBROUS SCAFFOLD FOR CELL CULTURING | CELLEVATE AB (SE) | 2024-06-27 | — | — | WO | disclosed |
| US-20240116872-A1 | PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING | GENENTECH, INC. (US) | 2024-04-11 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| US-6191171-B1 | ANTAGONISTS, USEFUL IN INHIBITION OR PREVENTION OF CELL ADHESION AND CELL-ADHESION MEDIATED PATHOLOGIES; FOR DRUGS FOR TREATMENT OF ASTHMA, ALLERGIES, INFLAMMATION, MULTIPLE SCLEROSIS, AND OTHER INFLAMMATORY AND AUTOIMMUNE DISORDERS | MERCK & CO., INC. | 2001-02-20 | — | — | US | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| WO-1999026923-A1 | PARA-AMINOMETHYLARYL CARBOXAMIDE DERIVATIVES | MERCK & CO., INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| EP-0874242-A1 | Device and apparatus for the simultaneous detection of multiple analytes | Randox Laboratories Ltd. (GB) | 1998-10-28 | — | — | EP | disclosed |
| CN-1197452-A | Azetidinone derivatives for treatment of atherosclerosis | SMITHKLINE BEECHAM PLC (GB) | 1998-10-28 | — | — | CN | disclosed |
| US-4578361-A | Creatinine antibody | BOEHRINGER MANNHEIM GMBH (DE) | 1986-03-25 | — | — | US | disclosed |
| US-4543325-A | Process and reagent for the determination of creatinine | BOEHRINGER MANNHEIM GMBH (DE) | 1985-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041430-A1 | CONJUGATE COMPOUND AND METHOD FOR PRODUCING CONJUGATE COMPOUND | C9, C3AR1, C5AR1 | TSHR 2885/4885TP53 3611/4885ALDH1A1 2220/4885 |
| US-12297302-B2 | Amphiphilic compound, and medical resin composition and pharmaceutical additive using the same | LIPA, ABHD16A, ABCB11 | TSHR 3598/4885TP53 2719/4885ALDH1A1 1842/4885 |
| US-20240116872-A1 | PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING | SHH, GLI1, SMO | TSHR 453/4885TP53 775/4885ALDH1A1 2371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.